Kraig Biocraft Laboratories, Inc. announced that production of its BAM-1 spider silk hybrid strain continues to set records for silkworm size, growth, and robustness. The Company announced in early June that it had accelerated its production schedule for its new BAM-1 hybrids based on the results of its spring production trials. The rearing of this first batch of production hybrids is now well underway.

The Company reported that this is not only the single production batch in its history but also the strongest growing and most robust production batch the Company has produced. At more than ten times the size of the spring trials, this production batch is pushing the Company's operational team to demonstrate the rapid scalability of its spider silk production technology. This production batch is validating the rearing protocols and systems put in place during the spring trials.

The Company expects to share reports on the results of the cocooning and processing of this batch of BAM-1 recombinant spider silk over the coming weeks. The Company continues to take bold moves as it aggressively moves forward, focusing on meeting its metric ton production targets.